management of patients with thalassemia who cannot undergo hsct or gene therapy
Published 2 years ago • 136 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
4:33
the assessment and management of pain in patients with thalassemia
-
2:31
the importance of vaccination in individuals with hemoglobinopathies and addressing educational gaps
-
0:54
gene therapy approaches to treating scd and thalassemia
-
5:49
beti-cel gene therapy for transfusion-dependent β-thalassemia: 7-year follow up data
-
1:07
tct highlights: long-term outcomes of beti-cel gene therapy for β-thalassemia
-
1:47
benefits of beti-cel gene therapy for transfusion-dependent β-thalassemia
-
1:32
bone disease in patients with thalassemia
-
0:38
pain management for patients with scd and thalassemia in lebanon
-
2:09
past, present, and future management strategies for non-transfusion dependent β-thalassemia
-
1:10
current and emerging therapeutic strategies in beta-thalassemia
-
8:38
treating transfusion dependent and independent beta-thalassemia, and believe/beyond trial updates
-
1:02
advancements in genetic screening improve personalized genetic counseling in scd and thalassemia
-
1:26
update on the energize trial of mitapivat in ntd alpha- and beta-thalassemia
-
1:48
toxicity of beti-cel in transfusion-dependent β-thalassemia
-
4:11
the demographics of patients with beta-thalassemia
-
4:25
latest news in cellular therapies
-
3:38
looking to the future in the treatment of beta thalassemia
-
2:18
a global view of transfusion-dependent thalassemia: standard of care, outcomes, and unmet needs
-
5:48
thalassemia: alpha & beta-thalassemias, genetics, pathophysiology, diagnosis & treatment, animation